"Simon Capewell, an emeritus professor of public health, raised ethical concerns about targeting individuals for economic reasons rather than health, calling it unethical to prioritize state interests over personal health and well-being."
"While the study initially focused on Novo Nordisk's Wegovy drug, it has now shifted to a pilot involving Lilly's Mounjaro, showcasing a different approach toward addressing obesity treatment in the UK through trials with significant participation."
Collection
[
|
...
]